Bristol Myers Squibb selects IQVIA Clinical Trial Payments for Payment Processing

In 2023, Bristol Myers Squibb, a United States based Life Sciences organization with 34100 employees and revenues of $48.3B selected IQVIA Clinical Trial Payments for Payment Processing while displacing Legacy, and integrating with the existing systems being used.

Customer	Vendor	Old Product	New Product	Category	Market	Users	VAR/SI	When	Live
Bristol Myers Squibb	IQVIA	Legacy	IQVIA Clinical Trial Payments	Payment Processing	ERP Financial Management	n/a	n/a	2023	2023

Discover the latest software purchases and digital transformation initiatives being undertaken by Bristol Myers Squibb and its business and technology executives by accessing the entire Bristol Myers Squibb and its business and technology executives by becoming a Premium Subscriber. On a continuous basis, our research team identifies and updates the on-prem and cloud applications that are being used by Bristol Myers Squibb employees from publicly available data (Press Releases, Customer References, Case Studies, Success Stories, Testimonials, RFP, RFI, etc.) as well as proprietary sources, and incorporate them into the customer profile.